Amgen Inc. (AMGN)
Nasdaq: AMGN · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA · filing with the SEC since 1994
Grade6.8
◀ Past 7.1● Present 7.7▶ Future 5.2
Filings
371 filings since 2017 beside 846 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 7, 2026.
Filings a yearinsider forms included
111126127126129115118121
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Oct 27, 2026.Serious cyber incident (8-K item 1.05): 1 time in the last 36 months, the newest Jul 31, 2026.SEC letters: 3 in the last 36 months, the newest May 10, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
40 of 371 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.